WEDNESDAY, April 13, 2022 (HealthDay News) — You’ve battled and beaten back a bout of cancer, so now you can take comfort in your victory, right? Wrong, claims new research that found most cancer patients and survivors fear their disease will return once treatment ends, a new analysis shows. ResearchersContinue Reading
WEDNESDAY, April 13, 2022 (HealthDay News) — Black Americans are far less likely to be included in clinical trials of pancreatic cancer drugs than white Americans, and eligibility criteria are a significant factor in that gap, according to a new study. “The standard of care in cancer treatment is informedContinue Reading
TUESDAY, April 12, 2022 (HealthDay News) — Quitting smoking can give heart disease patients nearly five additional years of life without heart problems, according to a new study. “Kicking the habit appears to be as effective as taking three medications for preventing heart attacks and strokes in those with aContinue Reading
MONDAY, April 11, 2022 (HealthDay News) — An immune system-based therapy that’s proven effective against blood cancers also might prove useful in battling solid tumor cancers, early clinical trial data show. A small group of patients with testicular and ovarian cancer appeared to respond well to “CAR-T” treatment with immuneContinue Reading
MONDAY, April 11, 2022 (HealthDay News) — Older Black American cancer patients have higher rates of frailty and disability than their white peers, which may help explain why Black patients also have higher cancer death rates, new research suggests. The researchers noted that Black patients are more likely to dieContinue Reading
MONDAY, April 11, 2022 (HealthDay News) — Some patients with serious illnesses get cosmetic surgery to look healthier and be more comfortable in social situations or at work, a small study finds. Researchers interviewed 12 patients who had cosmetic surgery at the start or during treatment for conditions such asContinue Reading
THURSDAY, April 7, 2022 (HealthDay News) — The introduction of HAART (highly active anti-retroviral therapy) in the mid-1990s revolutionized the treatment of HIV/AIDS, halting disease progression and dramatically extending lives. Now, a small new study suggests another potential use for one of the standard HAART medications: It halted disease progressionContinue Reading
THURSDAY, April 7, 2022 (HealthDay News) — Breast cancers that arise before age 40 tend to be more aggressive. But young women who undergo “breast-conserving” surgery are just as likely to survive as those who have a mastectomy, a preliminary study finds. The study involved nearly 600 women under ageContinue Reading
WEDNESDAY, April 6, 2022 (HealthDay News) — Vaccines did a good job protecting most cancer patients against COVID-19, but those with blood cancers remain at risk for breakthrough infections, new research suggests. The study analyzed nationwide data on more than 64,000 U.S. cancer patients who were vaccinated against SARS-CoV-2. TheContinue Reading
WEDNESDAY, April 6, 2022 (HealthDay News) — A proposed rule to ban ongoing uses of the only known form of asbestos imported into the United States has been introduced by the U.S. Environmental Protection Agency (EPA). The ban would apply to chrysotile asbestos, which is known to cause cancer andContinue Reading